This volume in the prestigious Methods in Enzymology series discusses methods currently used in preclinical and clinical gene therapy. Subjects covered in this book, such as the use of adeno-associated virus delivery for treatment of Parkinson's disease, are topical and are presented in the methods-oriented style popularized by this series.
- Discusses methods currently used in preclinical and clinical gene therapy
- Covers the use of adeno-associated virus delivery for treatment of Parkinson's disease
Inhaltsverzeichnis
1;Cover;1 2;Table of Contents;6 3;Contributors to Volume 346;12 4;Preface;20 5;Volumes in Series;22 6;Section I: Nonviral;42 6.1;Chapter 1. Gene Therapy for Hypertension: The Preclinical Data;44 6.2;Chapter 2. Oligonucleotide-Mediated Site-Directed Gene Repair;55 6.3;Chapter 3. Stabilized Plasmid-Lipid Particles: A Systemic Gene Therapy Vector;77 6.4;Chapter 4. Enhancing Direct in Vivo Transfection with Nuclease Inhibitors and Pulsed Electrical Fields;113 6.5;Chapter 5. Hydrodynamics-Based Transfection: Simple and Efficient Method for Introducing and Expressing Transgenes in Animals by Intravenous Injection of DNA;133 6.6;Chapter 6. Bioplex Technology: Novel Synthetic Gene Delivery System Based on Peptides Anchored to Nucleic Acids;147 6.7;Chapter 7. Surgical Procedures for Intravascular Delivery of Plasmid DNA to Organs;166 6.8;Chapter 8. Direct Gene Transfer into Mouse Heart;175 7;Section II: Adenovirus;184 7.1;Chapter 9. Myoblast-Mediated Gene Transfer for Therapeutic Angiogenesis;186 7.2;Chapter 10. Use of Phage Display to Identify Novel Peptides for Targeted Gene Therapy;198 7.3;Chapter 11. Helper-Dependent Adenoviral Vectors;218 7.4;Chapter 12. Gene Transfer Methods for Transplantation;240 7.5;Chapter 13. Generation and Growth of Gutted Adenoviral Vectors;265 7.6;Chapter 14. Adenovirus-Mediated Gene Transfer for Cardiovascular and Renal Diseases;288 7.7;Chapter 15. Gene Transfer to Blood Vessels Using Adenoviral Vectors;304 7.8;Chapter 16. Rearrangements in Adenoviral Genomes Mediated by Inverted Repeats;318 7.9;Chapter 17. High-Capacity, Helper-Dependent, Gutless AdenoviralVectors for Gene Transfer into Brain;333 7.10;Chapter 18. Gene Therapy Methods in Cardiovascular Diseases;352 8;Section III: Adeno-Associated Virus;362 8.1;Chapter 19. Gene Delivery to Cardiac Muscle;364 8.2;Chapter 20. Recombinant AAV-Mediated Gene Delivery Using Dual Vector Heterodimerization;375 8.3;Chapter 21. Designing and Characterizing Hammerhead Ribozymes for Use in AAV Vector-Media
ted Retinal Gene Therapies;399 8.4;Chapter 22. Adeno-Associated Viral Vector-Mediated Gene Therapy of Ischemia-Induced Neuronal Death;419 8.5;Chapter 23. Recombinant Adeno-Associated Viral Vector Production Using Stable Packaging and Producer Cell Lines;434 8.6;Chapter 24. Streamlined Large-Scale Production of Recombinant Adeno-Associated Virus (rAAV) Vectors;454 9;Section IV: Lentivirus;472 9.1;Chapter 25. Gene Transfer to the Brain Using Feline Immunodeficiency Virus-Based Lentivirus Vectors;474 9.2;Chapter 26. Generation of HIV-1 Derived Lentiviral Vectors;495 9.3;Chapter 27. Design, Production, Safety, Evaluation, and Clinical Applications of Nonprimate Lentiviral Vectors;507 9.4;Chapter 28. Gene Transfer to Airway Epithelia Using Feline Immunodeficiency Virus-Based Lentivirus Vectors;541 9.5;Chapter 29. Transduction of a Gene Expression Cassette Using Advanced Generation Lentiviral Vectors;555 9.6;Chapter 30. Construction, Purification, and Characterization of Adenovirus Vectors Expressing Apoptosis- Inducing Transgenes;570 10;Section V: Retrovirus;590 10.1;Chapter 31. Ligand-Inducible Transgene Regulation for Gene Therapy;592 10.2;Chapter 32. Large-Scale Production of Retroviral Vectors for Systemic Gene Delivery;603 10.3;Chapter 33. Oncoretroviral and Lentiviral Vector-Mediated Gene Therapy;614 11;Section VI: Other Strategies;632 11.1;Chapter 34. HSV-1 Amplicon Vectors;634 11.2;Chapter 35. Microencapsulation of Genetically Engineered Cells for Cancer Therapy;644 11.3;Chapter 36. HVJ (Hemagglutinating Virus of Japan; Sendai Virus)-Liposome Method;660 11.4;Chapter 37. Gene Transfer with Foamy Virus Vectors;669 11.5;Chapter 38. Infectious EpsteinBarr Virus Vectors for Episomal Gene Therapy;690 12;Author Index;702 13;Subject Index;752